Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Defects in homologous recombination repair genes are associated with good prognosis and clinical sensitivity to DNA-damaging agents in pancreatic cancer: A case report.

Sonnenblick A, Zick A, Maoz M, Cohen S, Kadouri L, Peretz T, Hubert A.

Mol Clin Oncol. 2018 May;8(5):683-685. doi: 10.3892/mco.2018.1588. Epub 2018 Mar 9.

2.

Ev vivo organ culture as potential prioritization tool for breast cancer targeted therapy.

Grinshpun A, Gavert N, Granit RZ, Masuri H, Ben-Porath I, Breuer S, Zick A, Rosenberg S, Maoz M, Granit A, Pikarsky E, Strausmman R, Peretz T, Sonnenblick A.

Cancer Biol Ther. 2018 Aug 3;19(8):645-648. doi: 10.1080/15384047.2018.1450114. Epub 2018 Apr 13.

PMID:
29565707
3.

Correction to: Cancer driver G-protein coupled receptor (GPCR) induced β-catenin nuclear localization: the transcriptional junction.

Nag JK, Rudina T, Maoz M, Grisaru-Granovsky S, Uziely B, Bar-Shavit R.

Cancer Metastasis Rev. 2018 Mar;37(1):197. doi: 10.1007/s10555-017-9721-x.

PMID:
29260351
4.

Cancer driver G-protein coupled receptor (GPCR) induced β-catenin nuclear localization: the transcriptional junction.

Nag JK, Rudina T, Maoz M, Grisaru-Granovsky S, Uziely B, Bar-Shavit R.

Cancer Metastasis Rev. 2018 Mar;37(1):147-157. doi: 10.1007/s10555-017-9711-z. Review. Erratum in: Cancer Metastasis Rev. 2017 Dec 20;:.

PMID:
29222765
5.

Low-density lipoprotein receptor-related protein 6 is a novel coreceptor of protease-activated receptor-2 in the dynamics of cancer-associated β-catenin stabilization.

Nag JK, Kancharla A, Maoz M, Turm H, Agranovich D, Gupta CL, Uziely B, Bar-Shavit R.

Oncotarget. 2017 Jun 13;8(24):38650-38667. doi: 10.18632/oncotarget.16246.

6.

Erratum to: Protease-activated-receptor-2 affects protease-activated-receptor-1-driven breast cancer.

Jaber M, Maoz M, Kancharla A, Agranovich D, Peretz T, Grisaru-Granovsky S, Uziely B, Bar-Shavit R.

Cell Mol Life Sci. 2017 Feb;74(3):571-577. doi: 10.1007/s00018-016-2424-6. No abstract available.

PMID:
27900391
7.

G Protein-Coupled Receptors in Cancer.

Bar-Shavit R, Maoz M, Kancharla A, Nag JK, Agranovich D, Grisaru-Granovsky S, Uziely B.

Int J Mol Sci. 2016 Aug 12;17(8). pii: E1320. doi: 10.3390/ijms17081320. Review.

8.

Identification of tissue-specific cell death using methylation patterns of circulating DNA.

Lehmann-Werman R, Neiman D, Zemmour H, Moss J, Magenheim J, Vaknin-Dembinsky A, Rubertsson S, Nellgård B, Blennow K, Zetterberg H, Spalding K, Haller MJ, Wasserfall CH, Schatz DA, Greenbaum CJ, Dorrell C, Grompe M, Zick A, Hubert A, Maoz M, Fendrich V, Bartsch DK, Golan T, Ben Sasson SA, Zamir G, Razin A, Cedar H, Shapiro AM, Glaser B, Shemer R, Dor Y.

Proc Natl Acad Sci U S A. 2016 Mar 29;113(13):E1826-34. doi: 10.1073/pnas.1519286113. Epub 2016 Mar 14.

9.

Protease-activated receptors (PARs) in cancer: Novel biased signaling and targets for therapy.

Bar-Shavit R, Maoz M, Kancharla A, Jaber M, Agranovich D, Grisaru-Granovsky S, Uziely B.

Methods Cell Biol. 2016;132:341-58. doi: 10.1016/bs.mcb.2015.11.006. Epub 2015 Dec 24. Review.

PMID:
26928551
10.

PH motifs in PAR1&2 endow breast cancer growth.

Kancharla A, Maoz M, Jaber M, Agranovich D, Peretz T, Grisaru-Granovsky S, Uziely B, Bar-Shavit R.

Nat Commun. 2015 Nov 24;6:8853. doi: 10.1038/ncomms9853.

11.

Protease-activated-receptor 1 polymorphisms correlate with risk for unexplained recurrent pregnancy loss: a pilot study querying an association beyond coagulation.

Grisaru-Granovsky S, Salah Z, Maoz M, Tevet A, Margalioth E, Samueloff A, Altarescu G, Bar-Shavit R.

Eur J Obstet Gynecol Reprod Biol. 2015 Feb;185:13-8. doi: 10.1016/j.ejogrb.2014.11.021. Epub 2014 Nov 25.

PMID:
25496845
12.

Protease-activated-receptor-2 affects protease-activated-receptor-1-driven breast cancer.

Jaber M, Maoz M, Kancharla A, Agranovich D, Peretz T, Grisaru-Granovsky S, Uziely B, Bar-Shavit R.

Cell Mol Life Sci. 2014 Jul;71(13):2517-33. doi: 10.1007/s00018-013-1498-7. Epub 2013 Nov 1. Erratum in: Cell Mol Life Sci. 2016 Nov 30;:.

PMID:
24177339
13.

Regulation of human protease-activated receptor 1 (hPar1) gene expression in breast cancer by estrogen.

Salah Z, Uziely B, Jaber M, Maoz M, Cohen I, Hamburger T, Maly B, Peretz T, Bar-Shavit R.

FASEB J. 2012 May;26(5):2031-42. doi: 10.1096/fj.11-194704. Epub 2012 Jan 30. Erratum in: FASEB J. 2017 Nov;31(11):5133-5134.

PMID:
22291441
14.

PAR1 plays a role in epithelial malignancies: transcriptional regulation and novel signaling pathway.

Bar-Shavit R, Turm H, Salah Z, Maoz M, Cohen I, Weiss E, Uziely B, Grisaru-Granovsky S.

IUBMB Life. 2011 Jun;63(6):397-402. doi: 10.1002/iub.452. Epub 2011 May 9. Review.

15.

DVL as a scaffold protein capturing classical GPCRs.

Turm H, Grisaru-Granvosky S, Maoz M, Offermanns S, Bar-Shavit R.

Commun Integr Biol. 2010 Nov;3(6):495-8. doi: 10.4161/cib.3.6.12979. Epub 2010 Nov 1.

16.

Par genes: molecular probes to pathological assessment in breast cancer progression.

Uziely B, Turm H, Maoz M, Cohen I, Maly B, Bar-Shavit R.

Patholog Res Int. 2011 Jan 24;2011:178265. doi: 10.4061/2011/178265.

17.

Etk/Bmx regulates proteinase-activated-receptor1 (PAR1) in breast cancer invasion: signaling partners, hierarchy and physiological significance.

Cohen I, Maoz M, Turm H, Grisaru-Granovsky S, Maly B, Uziely B, Weiss E, Abramovitch R, Gross E, Barzilay O, Qiu Y, Bar-Shavit R.

PLoS One. 2010 Jun 15;5(6):e11135. doi: 10.1371/journal.pone.0011135. Erratum in: PLoS One. 2010;5(12) doi: 10.1371/annotation/7ed84180-ec3d-46c0-8c10-f7b830999f8d.

18.

Protease-activated receptor-1 (PAR1) acts via a novel Galpha13-dishevelled axis to stabilize beta-catenin levels.

Turm H, Maoz M, Katz V, Yin YJ, Offermanns S, Bar-Shavit R.

J Biol Chem. 2010 May 14;285(20):15137-48. doi: 10.1074/jbc.M109.072843. Epub 2010 Mar 11.

19.

Protease activated receptor-1, PAR1, promotes placenta trophoblast invasion and beta-catenin stabilization.

Grisaru-Granovsky S, Maoz M, Barzilay O, Yin YJ, Prus D, Bar-Shavit R.

J Cell Physiol. 2009 Mar;218(3):512-21. doi: 10.1002/jcp.21625.

PMID:
19040205
20.

p53 controls hPar1 function and expression.

Salah Z, Haupt S, Maoz M, Baraz L, Rotter V, Peretz T, Haupt Y, Bar-Shavit R.

Oncogene. 2008 Nov 20;27(54):6866-74. doi: 10.1038/onc.2008.324. Epub 2008 Sep 29.

PMID:
18820708
21.
22.

Protease-activated receptor-1 (hPar1), a survival factor eliciting tumor progression.

Salah Z, Maoz M, Pokroy E, Lotem M, Bar-Shavit R, Uziely B.

Mol Cancer Res. 2007 Mar;5(3):229-40.

23.

Isolation and Identification of a New Antifungal Sesquiterpene Lactone from Inula viscosa.

Maoz M, Kashman Y, Neeman I.

Planta Med. 1999 Apr;65(3):281-2.

PMID:
17260308
24.

Mammary gland tissue targeted overexpression of human protease-activated receptor 1 reveals a novel link to beta-catenin stabilization.

Yin YJ, Katz V, Salah Z, Maoz M, Cohen I, Uziely B, Turm H, Grisaru-Granovsky S, Suzuki H, Bar-Shavit R.

Cancer Res. 2006 May 15;66(10):5224-33.

25.

Identification of a novel functional androgen response element within hPar1 promoter: implications to prostate cancer progression.

Salah Z, Maoz M, Cohen I, Pizov G, Pode D, Runge MS, Bar-Shavit R.

FASEB J. 2005 Jan;19(1):62-72.

PMID:
15629896
26.

Differential expression of protease activated receptor 1 (Par1) and pY397FAK in benign and malignant human ovarian tissue samples.

Grisaru-Granovsky S, Salah Z, Maoz M, Pruss D, Beller U, Bar-Shavit R.

Int J Cancer. 2005 Jan 20;113(3):372-8.

27.

The pattern of expression of protease-activated receptors (PARs) during early trophoblast development.

Even-Ram SC, Grisaru-Granovsky S, Pruss D, Maoz M, Salah Z, Yong-Jun Y, Bar-Shavit R.

J Pathol. 2003 May;200(1):47-52.

PMID:
12692840
28.

Human protease-activated receptor 1 expression in malignant epithelia: a role in invasiveness.

Yin YJ, Salah Z, Grisaru-Granovsky S, Cohen I, Even-Ram SC, Maoz M, Uziely B, Peretz T, Bar-Shavit R.

Arterioscler Thromb Vasc Biol. 2003 Jun 1;23(6):940-4. Epub 2003 Mar 13.

PMID:
12637343
29.

Oncogenic transformation induces tumor angiogenesis: a role for PAR1 activation.

Yin YJ, Salah Z, Maoz M, Even Ram SC, Ochayon S, Neufeld G, Katzav S, Bar-Shavit R.

FASEB J. 2003 Feb;17(2):163-74.

PMID:
12554695
30.

Signalling pathways induced by protease-activated receptors and integrins in T cells.

Bar-Shavit R, Maoz M, Yongjun Y, Groysman M, Dekel I, Katzav S.

Immunology. 2002 Jan;105(1):35-46.

31.

Gonadotropin stimulation of MLS human epithelial ovarian carcinoma cells augments cell adhesion mediated by CD44 and by alpha(v)-integrin.

Schiffenbauer YS, Meir G, Maoz M, Even-Ram SC, Bar-Shavit R, Neeman M.

Gynecol Oncol. 2002 Feb;84(2):296-302.

PMID:
11812090
32.

Tumor cell invasion is promoted by activation of protease activated receptor-1 in cooperation with the alpha vbeta 5 integrin.

Even-Ram SC, Maoz M, Pokroy E, Reich R, Katz BZ, Gutwein P, Altevogt P, Bar-Shavit R.

J Biol Chem. 2001 Apr 6;276(14):10952-62. Epub 2001 Jan 26.

33.

Effect of Inula viscosa extract on chitin synthesis in dermatophytes and Candida albicans.

Maoz M, Neeman I.

J Ethnopharmacol. 2000 Aug;71(3):479-82.

PMID:
10940586
34.

Protection of thrombin receptor expression under hypoxia.

Landau E, Tirosh R, Pinson A, Banai S, Even-Ram S, Maoz M, Katzav S, Bar-Shavit R.

J Biol Chem. 2000 Jan 28;275(4):2281-7.

35.

Thrombin receptor overexpression in malignant and physiological invasion processes.

Even-Ram S, Uziely B, Cohen P, Grisaru-Granovsky S, Maoz M, Ginzburg Y, Reich R, Vlodavsky I, Bar-Shavit R.

Nat Med. 1998 Aug;4(8):909-14.

PMID:
9701242
37.

Specific involvement of glypican in thrombin adhesive properties.

Bar-Shavit R, Maoz M, Ginzburg Y, Vlodavsky I.

J Cell Biochem. 1996 May;61(2):278-91. Erratum in: J Cell Biochem 1996 Jul;62(1):144.

PMID:
9173091
38.

The involvement of thrombin RGD in metastasis: characterization of a cryptic adhesive site.

Bar-Shavit R, Ginzburg Y, Maoz M, Vlodavsky I, Peretz T.

Isr J Med Sci. 1995 Feb-Mar;31(2-3):86-94.

PMID:
7744600

Supplemental Content

Support Center